首页> 外国专利> IN VITRO METHOD AND KIT FOR THE PROGNOSIS OR PREDICTION OF THE RESPONSE TO TREATMENT WITH ANTI-PSYCHOTIC AGENTS IN PATIENTS WHO HAVE SUFFERED FIRST EPISODE PSYCHOSIS

IN VITRO METHOD AND KIT FOR THE PROGNOSIS OR PREDICTION OF THE RESPONSE TO TREATMENT WITH ANTI-PSYCHOTIC AGENTS IN PATIENTS WHO HAVE SUFFERED FIRST EPISODE PSYCHOSIS

机译:体外方法和试剂盒用于预防或预测患有首发性精神分裂症的患者对抗精神分裂症药物治疗的反应

摘要

The present invention relates to an in vitro method for the prognosis or prediction of the response to treatment with anti-psychotic drugs in subjects who have suffered first episode psychosis (FEP), and specifically to the use of the expression value, in a biological sample isolated from said subjects, of the ratio formed by two of the isoforms – active isoform and truncated isoform – of the receptor (TrKB) of the nerve growth factor BDNF, named TrKB-FL and TrkB-T, respectively. The present invention also describes kits and uses of same to implement the method of the invention.
机译:本发明涉及一种体外方法,其用于在患有第一次发作性精神病(FEP)的受试者中预后或预测对使用抗精神病药治疗的反应,特别是涉及在从上述受试者中分离出的生物学样本中,神经生长因子BDNF受体(TrKB-FL和TrkB-T)的两个同工型(活性同工型和截短同工型)形成的比率的表达值,分别。本发明还描述了试剂盒及其用于实施本发明方法的用途。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号